ABT 378/r: a novel inhibitor of HIV-1 protease in haemodialysis.
Izzedine
H
H
Launay-Vacher
V
V
Legrand
M
M
Lieberherr
D
D
Caumes
E
E
Deray
G
G
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy; D000666:Amphotericin B / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000652:urine*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D006801:Humans; D007896:Leishmaniasis / Q000188:drug therapy; D061466:Lopinavir; D008297:Male; D011744:Pyrimidinones / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D006435:Renal Dialysis; D051437:Renal Insufficiency / Q000097:blood / Q000150:complications / Q000628:therapy / Q000652:urine; D019438:Ritonavir / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use
D000981:Antiprotozoal Agents; D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir; D000666:Amphotericin B; D019438:Ritonavir